Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) advises that all resolutions put to the Company’s annual shareholders’ meeting held in Auckland today were passed. The seven resolutions were:
Resolution 1: To re-elect Roger France as a Director.
Resolution 2: To re-elect Arthur Morris as a Director.
Resolution 3: To elect Michael Daniell as a Director.
Resolution 4: To authorise the Directors to fix the fees and expenses of the Company’s auditor.
Resolution 5: To approve the issue of share rights to Michael Daniell as set out in the Notice of Annual Shareholders’ Meeting 2012.
Resolution 6: To approve the issue of options to Michael Daniell as set out in the Notice of Annual Shareholders’ Meeting 2012.
Resolution 7: To approve the Fisher & Paykel Healthcare Corporation Limited Stock Purchase Plan.
All resolutions were decided by poll. The details of the total number of votes cast in person or by proxy on the polls were as follows:
Resolution Votes For Votes Against Total Votes Cast Abstain
Resolution 1: Re-election of Roger France 335,550,277 1,048,669 336,598,946 198,863
Resolution 2: Re-election of Arthur Morris 335,424,798 942,017 336,366,815 240,494
Resolution 3: Election of Michael Daniell 333,420,429 2,365,118 335,785,547 995,316
Resolution 4: Authorise Directors to fix fees and expenses of auditor 336,021,393 349,960 336,371,353 218,410
Resolution 5: Issue of share rights to Michael Daniell 325,867,820 7,930,161 333,797,981 1,269,406
Resolution 6: Issue of options to Michael Daniell 287,458,317 47,186,900 334,645,217 405,224
Resolution 7: Approval of Fisher & Paykel Healthcare Corporation Limited Stock Purchase Plan 335,831,790 467,045 336,298,835 284,012
Announcement regarding Directors
At the annual shareholders’ meeting, Tony Carter announced that both Gary Paykel and Nigel Evans have indicated that they plan to retire from the board at the Company’s 2013 annual shareholders’ meeting. The Company is currently searching for a director who has global experience in medical device manufacturing and hope to make an appointment in the near future. Next year, the Company will also commence a search for a second director to ensure a smooth transition when Gary Paykel and Nigel Evans retire.
Independence of Directors
In accordance with NZX Listing Rule 3.3.3(a), the Board has determined that Tony Carter, Nigel Evans, Roger France, Lindsay Gillanders, Arthur Morris and Gary Paykel are independent directors.
The factors that the Board considers in assessing the independence of directors are set out in the Board Charter, which can be viewed on the Company’s website: www.fphcare.com.
Contact: Tony Barclay, Company Secretary on +64 9 574 0119. For more information about the company visit our website www.fphcare.com
ASM 2012 Meeting Results, Director Announcements and Director Independence
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Providing Optimal Humidity for intubated patients
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment
This access is intended for health professionals only and by accessing it you agree to be a health professional.
I am a health professional. P>
Remember my choice